Early Bacterial Colonization and Antibiotic Resistance Gene Acquisition in Newborns

Front Cell Infect Microbiol. 2020 Jul 10:10:332. doi: 10.3389/fcimb.2020.00332. eCollection 2020.

Abstract

Several studies have recently identified the main factors contributing to the bacterial colonization of newborns and the dynamics of the infant microbiome development. However, most of these studies address large time periods of weeks or months after birth, thereby missing on important aspects of the early microbiome maturation, such as the acquisition of antibiotic resistance determinants during postpartum hospitalization. The pioneer bacterial colonization and the extent of its associated antibiotic resistance gene (ARG) dissemination during this early phase of life are largely unknown. Studies addressing resistant bacteria or ARGs in neonates often focus only on the presence of particular bacteria or genes from a specific group of antibiotics. In the present study, we investigated the gut-, the oral-, and the skin-microbiota of neonates within the first 72 h after birth using 16S rDNA sequencing approaches. In addition, we screened the neonates and their mothers for the presence of 20 different ARGs by directed TaqMan qPCR assays. The taxonomic analysis of the newborn samples revealed an important shift of the microbiota during the first 72 h after birth, showing a clear site-specific colonization pattern in this very early time frame. Moreover, we report a substantial acquisition of ARGs during postpartum hospitalization, with a very high incidence of macrolide resistance determinants and mecA detection across different body sites of the newborns. This study highlights the importance of antibiotic resistance determinant dissemination in neonates during hospitalization, and the need to investigate the implication of the mothers and the hospital environment as potential sources of ARGs.

Keywords: 16S rDNA sequencing; antibiotic resistance gene; microbiome; neonatology; newborns.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Bacteria / genetics
  • Drug Resistance, Bacterial / genetics
  • Female
  • Genes, Bacterial / genetics
  • Humans
  • Infant
  • Infant, Newborn
  • Macrolides
  • Microbiota*
  • RNA, Ribosomal, 16S / genetics

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • RNA, Ribosomal, 16S